Trial Profile

An Open-label Study of ALPN-101 in Steroid-resistant or Steroid-refractory Acute Graft Versus Host Disease (aGVHD)

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 30 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Acazicolcept (Primary)
Indications Graft-versus-host disease
Focus Adverse reactions
Acronyms BALANCE
Sponsors Alpine Immune Sciences

Most Recent Events

24 Aug 2020 Status changed from recruiting to discontinued due to change in sponsor strategy.
25 Mar 2020 Status changed from not yet recruiting to recruiting.
06 Nov 2019 Trial design released at the 61st Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem 2019).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com